Role of oxidant injury on macrophage lipoprotein lipase (LPL) production and sensitivity to LPL

Journal of Lipid Research

Volumn 37, Issue 4, 1996, Pages 799-809

  Renier, Geneviève ^a   Desfaits, Anne Cécile ^a   Lambert, Anick ^a   Mikhail, Roland ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

atherosclerosis; hydrogen peroxide; oxidative stress; reactive oxygen intermediates

Indexed keywords

ACETYLCYSTEINE; ALLOPURINOL; ANTIOXIDANT; BUTYLCRESOL; CALPHOSTIN C; DEFEROXAMINE; DIMETHYL SULFOXIDE; HYDROGEN PEROXIDE; LIPOPROTEIN LIPASE; MANNITOL; MESSENGER RNA; PROTEIN KINASE C INHIBITOR; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; ARTERIOSCLEROSIS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; DRUG RESISTANCE; GENE EXPRESSION; HUMANS; HYDROGEN PEROXIDE; LIPOPROTEIN LIPASE; MACROPHAGES; MICE; MOLECULAR SEQUENCE DATA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029874894     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Sparrow, C. P., and J. Olszewski. 1992. Cellular oxidative modification of low density lipoprotein does not require lipooxygenases. Proc. Natl. Acad. Sci. USA. 89: 128-131.
2. Morel, D. W., P. E. DiCorleto, and G. M. Chisolm. 1984. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 4: 357-364.
3. Steinberg, D. 1993. Modified forms of low density lipoprotein and atherosclerosis. J. Intern. Med. 233: 227-232.
4. Aviram, M. 1993. Modified forms of low density lipoprotein and atherogenesis. Atherosclerosis. 98: 1-9.
5. Witztum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
6. Crawford, D. W., and D. H. Blankenhorn. 1991. Arterial wall oxygenation, oxyradicals and atherosclerosis. Atherosclerosis. 89: 97-108.
7. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
8. Jurgens, G., H. F. Hoff, G. M. Chisolm, and H. Esterbauer. 1987. Modification of human serum low density lipoprotein by oxidation: characterization and pathophysiological implications. Chem. Phys. Lipids. 45: 315-336.
9. Aviram, M. 1990. Malondialdehyde affects the physicochemical and biological characteristics of oxidized low density lipoprotein. Atherosclerosis. 84: 141-143.
10. Aviram, M., and D. Presser. 1990. Platelet secretory substances enhance in vitro plasma coagulation. Isr. J. Med. Sci. 26: 585-587.
11. Schuff-Werner, P., G. Claus, V. W. Armstrong, H. L. Kostering, and D. Seidel. 1989. Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL. Atherosclerosis. 78: 109-112.
12. Rajavashisth, T. B., A. Andalibi, M. T. Territo, J. A. Berliner, M. Navab, A. M. Fogelman, and A. J. Lusis. 1990. Induction of endothelial cell expression of granulocyte macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 344: 254-257.
13. Liao, F., J. A. Berliner, M. Mehrabian, M. Navab, L. Demer, A. J. Lusis, and A. M. Fogelman. 1991. Minimally modified low density lipoprotein is biologically active in vivo. J. Clin. Invest. 87: 2253-2257.
14. Leslie, C. C., R. A. Mussen, and P. M. Henson. 1984. Production of growth factor activity for utilization by human monocyte-derived macrophages. J. Biol. Chem. 36: 143-149.
15. Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J. 10: 2247-2258.
16. Chaudhri, G., and I. A. Clark. 1989. Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor. J. Immunol. 143: 1290-1294.
17. Rao, G. N., and B. C. Berk. 1992. Active oxygen species stimulate vascular smooth muscle cell growth and protooncogene expression. Circ. Res. 70: 593-599.
18. Eckel, R. H. 1989. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. N. Engl. J. Med. 320: 1060-1068.
19. Khoo, J. C., E. M. Mahoney, and J. L. Witztum. 1981. Secretion of lipoprotein lipase by macrophages in culture. J. Biol. Chem. 256: 7105-7108.
20. Renier, G., E. Skamene, J. B. DeSanctis, and D. Radzioch. 1994. Induction of tumor necrosis factor ot gene expression by lipoprotein lipase. J. Lipid Res. 35: 271-278.
21. Yla-Herttuala, S., B. A. Lipton, M. E. Rosenfeld, I. J. Goldberg, D. Steinberg, and J. L. Witztum. 1991. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 88: 10143-10147.
22. Saxena, U., M. G. Klein, T. M. Vanni, and I. J. Goldberg. 1992. Lipoprotein lipase-mediated increase in low density lipoprotein (LDL) retention by subendothelial cell matrix. J. Clin. Invest. 89: 373-380.
23. Rutledge, J. C., and I. J. Goldberg. 1994. Lipoprotein lipase (LPL) affects low density lipoprotein (LDL) flux through vascular tissue: evidence that LPL increases LDL accumulation in vascular tissue. J. Lipid Res. 35: 1152-1160.
24. Cox, G., L. Gandino, E. Blasi, D. Radzioch, B. J. Mathieson, and L. Varesio. 1989. Heterogeneity of hematopoietic cells immortalized with v/myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J. Natl. Cancer Inst. 81: 1492-1496.
25. Fredrickson, D. S., J. L. Goldstein, and M. S. Brown. 1978. The familial hyperlipoproteinemias. In The Metabolic Basis of Inherited Disease. J. B. Standbury, J. B. Wyngaarden, and D. S. Fredrickson, editors. McGraw-Hill, New York, NY. 604-655.
26. Renier, G., E. Skamene, J. B. DeSanctis, and D. Radzioch. 1993. High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis. Arterioscler. Thromb. 13: 190-196.
27. Sivaram, P., S. Wadhwani, M. G. Klein, A. Sasaki, and I. J. Goldberg. 1993. Biotinylation of lipoprotein lipase and hepatic lipase: application in the assessment of cell binding sites. Anal. Biochem. 214: 511-516.
28. Saxena, U., L. D. Witte, and I. J. Goldberg. 1989. Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids. J. Biol. Chem. 264: 4349-4355.
29. Chirgwin, J. M., A. E. Przybyla, R. S. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acids from sources enriched in ribonucleases. Biochemistry. 18: 5294-5299.
30. Thomas, P. 1980. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA. 77: 5201-5205.
31. Sheehan, K. C. F., N. H. Ruddle, and R. D. Schreiber. 1989. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J. Immunol. 142: 3884-3893.
32. Goers, J. W. F., M. E. Pedersen, P. A. Kern, J. Ong, and M. Schotz. 1987. An enzyme-linked immunoassay for tipoprotein lipase. Anal. Biochem. 166: 27-35.
33. Bradford, M. M. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle protein-dye binding. Anal. Biochem. 72: 248-254.
34. Baud, L., H. Affres, J. Perez, and R. Ardaillou. 1990. Reduction in tumor necrosis factor binding and cytotoxicity by hydrogen peroxide. J. Immunol. 145: 556-560.
35. Friedman, G., T. Chajek-Shaul, R. Gallily, O. Stein, E. Shiloni, J. Etienne, and Y. Stein. 1988. Modulation of lipoprotein lipase activity in mouse peritoneal macrophages by recombinant human tumor necrosis factor. Biochim. Biophys. Acta. 963: 201-207.
36. Granger, D. M., M. E. Hoellwarth, and D. A. Parks. 1986. Ischemia-reperfusion injury: role of oxygen-derived free radicals. Acta Physiol. Scand. 548: 47-63.
37. Kontos, H. A., E. P. Wei, J. T. Povlishock, and C. W. Christman. 1985. George E. Brown memorial lecture. Oxygen radicals in cerebral vascular injury. Circ. Res. 57: 508-516.
38. Steinbrecher, U. P., S. Parthasarathy, D. S. Leake, J. L. Witztum, and D. Steinberg. 1984. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA, 81: 3883-3887.
39. Chaudhri, G. I., I. A. Clark, N. H. Hunt, W. B. Cowden, and R. Ceredig. 1986. Effects of antioxidants on primary alloantigen-induced T cell activation and proliferation. J. Immunol. 137: 2646-2652.
40. Chaudhri, G. I., N. H. Hunt, I. A. Clark, and R. Ceredig. 1988. Antioxidants inhibit proliferation and cell surface expression of receptors for interleukin-2 and transferrin in T lymphocytes stimulated with phorbol myristate acetate and ionomycin. Cell Immunol. 115: 204-213.
41. Eugui, E. M., B. Delustro, S. Rouhafza, R. Wilhelm, and A. C. Allison. 1993. Coordinate inhibition by some antioxidants of TNFα, IL-1β, and IL-6 production by human peripheral blood mononuclear cells. Ann. NY Acad. Sci. 696: 171-184.
42. DeForge, L. E., J. C. Fantone, J. S. Kenney, and D. G. Remick. 1992. Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. J. Clin. Invest. 90: 2123-2129.
43. 2. Am. J. Physiol. 256: H1012-H1022.
44. Pradines-Figuères, A., S. Barcellini-Couget, C. Dani, C. Vannier, and G. Ailhaud. 1990. Transcriptional control of the expression of lipoprotein lipase gene by growth hormone in preadipocyte Ob1771 cells. J. Lipid Res. 31: 1283-1291.
45. Klebanoff, S. J., M. A. Vadas, J. M. Harlan, L. H. Sparks, J. R. Gamble, J. M. Agosti, and A. M. Waltersdorph. 1986. Stimulation of neutrophils by tumor necrosis factor. J. Immunol. 136: 4220-4225.
46. Homan-Muller, J. W. T., R. S. Weening, and D. Roos. 1975. Production of hydrogen peroxide by phagocytizing human granulocytes. J. Lab. Clin. Med. 85: 198-207.
47. Mori, N., T. Gotoda, S. Ishibashi, H. Shimano, K. Harada, T. Inaba, F. Takaku, Y. Yazaki, and N. Yamada. 1991. Effects of human recombinant macrophage colony-stimulating factor on the secretion of lipoprotein lipase from macrophages. Arteriosclerosis. 11: 1315-1321.